Area of research
Infectious Diseases · Genetics
Research interest
Research interests include Medicine, Clinical endpoint, Internal medicine, Mucormycosis, Adverse effect, and Aspergillosis.
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia
Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Interim results from the phase 2 study FIDES-01.
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the <scp>VITAL</scp> trial
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia